Asiatic acid prevents glucocorticoid-induced femoral head osteonecrosis via PI3K/AKT pathway

• Published in: International immunopharmacology 2024-03, Vol.130, p.111758-111758, Article 111758
• Main Authors: Lin, Chihao, Jiang, Hongyi, Lou, Chao, Wang, Weidan, Cai, Tingwen, Lin, Zhongnan, Jiang, Liting, Lin, Shida, Xue, Xinghe, Pan, Xiaoyun
• Format: Article
• Language: English
• ISSN: 1567-5769; 1878-1705
• DOI: 10.1016/j.intimp.2024.111758

[Display omitted] •Asiatic Acid (AA) has therapeutic potential for glucocorticoid-induced osteonecrosis of the femoral head (GIONFH).•AA prevents GIONFH may related to anti-apoptosis and alleviation of oxidative stress.•AA can inhibit GIONFH by modulating the PI3K/AKT signaling pathway. Glucocorticoid-induced osteonecrosis of the femoral head (GIONFH) represents a predominant etiology of non-traumatic osteonecrosis, imposing substantial pain, restricting hip mobility, and diminishing overall quality of life for affected individuals. Centella asiatica (L.) Urb. (CA), an herbal remedy deeply rooted in traditional oriental medicine, has exhibited noteworthy therapeutic efficacy in addressing inflammation and facilitating wound healing. Drawing from CA's historical applications, its anti-inflammatory, anti-apoptotic, and antioxidant attributes may hold promise for managing GIONFH. Asiatic acid (AA), a primary constituent of CA, has been substantiated as a key contributor to its anti-apoptotic, antioxidant, and anti-inflammatory capabilities, showcasing a close association with orthopedic conditions. For the investigation of whether AA could alleviate GIONFH through suppressing oxidative stress, apoptosis, and to delve into its potential cellular and molecular mechanisms, the connection between AA and disease was analyzed through network pharmacology. DEX-induced apoptosis in rat osteoblasts and GIONFH in rat models, got utilized for the verification in vitro/vivo, on underlying mechanism of AA in GIONFH. Network pharmacology analysis reveals a robust correlation between AA and GIONFH in multiple target genes. AA has demonstrated the inhibition of DEX-induced osteoblast apoptosis by modulating apoptotic factors like BAX, BCL-2, Cleaved-caspase3, and cleaved-caspase9. Furthermore, it effectively diminishes the ROS overexpression and regulates oxidative stress through mitochondrial pathway. Mechanistic insights suggest that AA's therapeutic effects involve phosphatidylinositol 3-kinase/Protein kinase B (PI3K/AKT) pathway activation. Additionally, AA has exhibited its potential to ameliorate GIONFH progression in rat models. Our findings revealed that AA mitigated DEX-induced osteoblast apoptosis and oxidative stress through triggering PI3K/AKT pathway. Also, AA can effectively thwart GIONFH occurrence and development in rats.